# TRANSGENRX INC: Form D filings

TRANSGENRX INC, a biotechnology company in Baton Rouge, LA, filed 3 Form D notices with the SEC between 2010 and 2011. The latest, on September 9, 2011, reports $6.5 million sold of a $15 million offering to 42 investors.

Find out what TRANSGENRX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20TRANSGENRX%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=TRANSGENRX%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Ftransgenrx-inc-1274562)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20TRANSGENRX%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=TRANSGENRX%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Ftransgenrx-inc-1274562)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Louisiana](https://specstream.ai/data/form-d/state/louisiana): 144 rows, by operating companies, filed since November 1, 2024, $7.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/louisiana
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 340 EAST PARKER BLVD, Baton Rouge, LA, 70803
- Phone: (888) 432-0721
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1274562

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 9, 2011 | Amendment | $15,000,000 | $6,505,600 | $8,494,400 | 42 | Oct 14, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274562/000114420411052058/0001144204-11-052058-index.htm) |
| Sep 28, 2010 | New notice | $10,000,000 | $0 | $10,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274562/000114420410051129/0001144204-10-051129-index.htm) |
| Aug 4, 2010 | New notice | Indefinite | $420,000 | Indefinite | 4 | Jul 20, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274562/000114420410040998/0001144204-10-040998-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Richard C. Cooper | Executive Officer, Director |  |
| William C. Fioretti | Executive Officer, Director |  |
| Robert B. Kenney | Director |  |
| John B. Gallagher | Executive Officer, Director |  |

## Other biotechnology companies in Louisiana that filed recently

- [28bio, Inc.](https://specstream.ai/data/form-d/company/28bio-inc-1769360) $8.5 million · Oct 29, 2026
- [Therapeutic Neuromodulation Systems LLC](https://specstream.ai/data/form-d/company/therapeutic-neuromodulation-systems-llc-2152054) $1.7 million · Sep 21, 2026

[Every Form D from the week of Sep 5, 2011](https://specstream.ai/data/form-d/week/2011-09-05) · [All recent filings in Louisiana](https://specstream.ai/data/form-d/state/louisiana) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what TRANSGENRX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).